We are live on
!
Find out more
CH
CVI Holdings Portfolio holdings
AUM
$116M
1-Year Est. Return
5.68%
This Fund
S&P 500
This Quarter
Est. Return
+29.74%
1 Year Est. Return
+5.68%
3 Year Est. Return
+25.77%
5 Year Est. Return
+327.29%
10 Year Est. Return
–
AUM
$106M
AUM Growth
+$60.7M
(+135%)
Cap. Flow
+$28.3M
Cap. Flow
% of AUM
26.83%
Top 10 Holdings %
Top 10 Hldgs %
81.35%
Holding
68
New
25
Increased
4
Reduced
9
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NSTG
NanoString Technologies, Inc.
NSTG
|
+$17.8M |
| 2 |
BPMC
Blueprint Medicines
BPMC
|
+$14.8M |
| 3 |
GNFT
Genfit
GNFT
|
+$9.23M |
| 4 |
SIOX
Sio Gene Therapies Inc. Common Stock
SIOX
|
+$7.09M |
| 5 |
EyePoint Inc
EYPT
|
+$3.53M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MannKind Corp
MNKD
|
+$16.2M |
| 2 |
SCPX
Scorpius Holdings, Inc.
SCPX
|
+$1.64M |
| 3 |
IRD
Opus Genetics
IRD
|
+$1.44M |
| 4 |
VLRX
VALERITAS HOLDINGS INC
VLRX
|
+$989K |
| 5 |
VBIV
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
|
+$585K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 68.47% |
| 2 | Communication Services | 5.16% |
| 3 | Technology | 1.99% |
| 4 | Consumer Discretionary | 0.75% |
| 5 | Materials | 0.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NSTG
1
DELISTED
NanoString Technologies, Inc.
NSTG
| $18.5M | 17.54% |
+774,068
| New | +$17.8M |
|
|
BPMC
2
DELISTED
Blueprint Medicines
BPMC
| $16M | 15.16% |
+200,000
| New | +$14.8M |
|
|
GNFT
3
DELISTED
Genfit
GNFT
| $9.6M | 9.09% |
+400,000
| New | +$9.23M |
|
|
SIOX
4
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $8.16M | 7.73% |
767,300
+712,158
| +1,291% | +$7.09M |
|
|
EMWP
5
DELISTED
Eros Media World PLC
EMWP
| $4.56M | 4.32% |
24,945
+11,006
| +79% | +$2.11M |
|
|
6
EyePoint Inc
EYPT
$999M
| $2.66M | 2.52% |
+148,471
| New | +$3.53M |
|
7
Spyre Therapeutics
SYRE
$8.5B
| $2.19M | 2.07% |
+10,862
| New | +$2.26M |
|
|
TMDI
8
DELISTED
Titan Medical Inc. Ordinary Shares
TMDI
| $2.13M | 2.02% |
+762,371
| New | +$2.5M |
|
9
vTv Therapeutics
VTVT
$124M
| $2.1M | 1.99% |
+30,729
| New | +$2.98M |
|
10
Oragenics
OGEN
$2.24M
| $1.98M | 1.88% |
+1,884
| New | +$2.96M |
|
11
Kopin
KOPN
$586M
| $1.86M | 1.76% |
+1,384,944
| New | +$1.86M |
|
|
NTBL
12
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
| $1.66M | 1.57% |
31,258
-8,793
| -22% | -$430K |
|
|
ADXS
13
DELISTED
Advaxis Inc
ADXS
| $1.24M | 1.18% |
210,570
+64,208
| +44% | +$365K |
|
14
Matinas BioPharma
MTNB
$1.91M
| $991K | 0.94% |
+18,193
| New | +$980K |
|
|
15
MannKind Corp
MNKD
$1.19B
| $908K | 0.86% |
461,140
-10,254,940
| -96% | -$16.2M |
|
16
Beasley Broadcasting Group
BBGI
$35.3M
| $894K | 0.85% |
11,237
-3,268
| -23% | -$283K |
|
|
CODX
17
Co-Diagnostics
CODX
$5.56M
| $751K | 0.71% |
+23,619
| New | +$850K |
|
18
Aptevo Therapeutics
APVO
$4.96M
| – | – |
0
| – | – |
|
|
SOLO
19
DELISTED
Electrameccanica Vehicles Corp. Ltd.
SOLO
| $693K | 0.66% |
+194,653
| New | +$527K |
|
|
FURY
20
Fury Gold Mines
FURY
$101M
| $679K | 0.64% |
316,312
-177,888
| -36% | -$293K |
|
|
MRSN
21
DELISTED
Mersana Therapeutics
MRSN
| $442K | 0.42% |
+3,359
| New | +$423K |
|
|
SCPX
22
DELISTED
Scorpius Holdings, Inc.
SCPX
| $440K | 0.42% |
12
-44
| -79% | -$1.64M |
|
23
Liquidia Corp
LQDA
$7.72B
| $330K | 0.31% |
+28,987
| New | +$465K |
|
|
CHMA
24
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $321K | 0.3% |
+61,805
| New | +$272K |
|
25
Moleculin Biotech
MBRX
$9.61M
| $294K | 0.28% |
+161
| New | +$480K |
|
Similar funds
EL
YSP
GIM
FWM
CPG
WCM
ETIA
RCM
CVI Holdings's Q1 2019 Portfolio in Review
As of Q1 2019, CVI Holdings held 68 positions worth $106M, up 135% from $44.9M the previous quarter. Its ten largest holdings account for 81% of the portfolio.
CVI Holdings deployed $28.3M of net new capital in Q1 2019, opening 25 new positions and adding to 4 existing holdings. Its largest new stake was NanoString Technologies, Inc.: 774,068 shares worth $18.5M.
By sector, the portfolio is most concentrated in Healthcare at 68% of assets, up from 42% a quarter earlier, followed by Communication Services and Technology.
On the sell side, the largest reduction was MannKind Corp, an estimated $16.2M trimmed.
- CVI Holdings's largest Q1 2019 buy was NanoString Technologies, Inc.: 774,068 shares worth $18.5M.
- CVI Holdings added most to Sio Gene Therapies Inc. Common Stock in Q1 2019, an estimated $7.09M increase.
- CVI Holdings's biggest Q1 2019 reduction was MannKind Corp, cutting an estimated $16.2M.
- CVI Holdings fully exited Opus Genetics in Q1 2019, selling an estimated $1.44M.
- CVI Holdings's ten largest holdings make up 81% of its $106M portfolio in Q1 2019.
- CVI Holdings opened 25 new positions and closed 9 in Q1 2019.
- CVI Holdings's portfolio value rose 135% quarter-over-quarter to $106M.
Based on CVI Holdings's 13F filing for Q1 2019, filed 15 May 2019.